多病共存队列选择偏倚对结局关联的影响:UK Biobank与代表性样本比较
该研究比较了UK Biobank队列(n=211,597,40-70岁)与全国代表性常规数据源SAIL(n=852,055,40-70岁)中多病共存与不良健康结局的关联。结果显示,UK Biobank中多病共存较少见,且在长期疾病计数≥4时低估了多病共存与死亡、非计划住院和主要不良心血管事件的风险关联,但计数≤3时关联估计相似。
要点
- UK Biobank在长期疾病计数≤3时可较准确估计多病共存与结局的关联。
- 长期疾病计数≥4时,UK Biobank对关联强度的估计可能偏保守。
- UK Biobank中部分长期疾病(如酒精问题、心理健康状况)的风险比被低估。
核心结论
- UK Biobank可准确估计长期疾病计数≤3时与结局的关联,但计数≥4时关联估计可能偏保守。
研究设计与样本
- 研究基于UK Biobank(n=211,597,40-70岁)和SAIL代表性样本(n=852,055,40-70岁)的常规医疗数据链接队列。
- 多病共存通过初级保健Read编码识别40种长期疾病,采用简单计数和加权评分量化。
- 使用Weibull或Poisson模型评估与全因死亡、非计划住院和MACE的关联,并调整年龄、性别和社会经济地位。
主要发现
- UK Biobank中多病共存较SAIL少见,按年龄、性别和社会经济地位标准化后差异减弱但持续存在。
- 长期疾病计数≤3时,多病共存对死亡、非计划住院和MACE的效应在UK Biobank与SAIL间相似;计数>3时UK Biobank低估风险。
- UK Biobank中所有多病共存水平下死亡、住院和MACE的绝对风险均低于SAIL(调整年龄、性别和社会经济地位后)。
- 部分长期疾病(如高血压和冠心病)的风险比在两队列中相似,但其他疾病(如酒精问题或心理健康状况)的风险比被低估。
- 部分长期疾病组合(如心血管、呼吸系统疾病)的风险比相似,但包含疼痛或心理健康状况的组合风险比被低估。
临床怎么用
- 使用UK Biobank数据评估多病共存(计数≥4)与结局关联时,应注意估计值可能偏保守。
- 对于包含心理健康状况或疼痛的长期疾病组合,UK Biobank的风险估计可能低估,临床解读需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Context: UK Biobank is increasingly used to study causes, associations, and implications of multimorbidity. However, UK Biobank is criticised for lack of representativeness and 'healthy volunteer bias'. Selection bias can lead to spurious or biased estimates of associations between exposures and outcomes. Objectives: To compare association between multimorbidity and adverse health outcomes in UK Biobank and a nationally representative sample. Design: Cohorts identified from linked routine healthcare data from UK Biobank and from the Secure Anonymised Information Linkage (SAIL) databank. Setting: Community. Participants: UK Biobank participants (n=211,597, age 40-70) with linked primary care data and a sample from a nationally representative routine data source (SAIL) (n=852,055, age 40-70). Main outcome measures: Multimorbidity (n=40 long-term conditions [LTCs]) was identified from primary care Read codes and quantified using a simple count and a weighted score. Individual LTCs and LTC combinations were also assessed. Associations with all-cause mortality, unscheduled hospitalisation, and major adverse cardiovascular events (MACE) were assessed using Weibull or Poisson models and adjusted for age, sex, and socioeconomic status. Results: Multimorbidity was less common in UK Biobank than SAIL. This difference was attenuated, but persisted, after standardising by age, sex and socioeconomic status. The effect of increasing multimorbidity count on mortality, unscheduled hospitalisation, and MACE was similar between UK Biobank and SAIL at LTC counts of ≤3, however above this level UK Biobank underestimated the risk associated with multimorbidity. Absolute risk of mortality, hospitalisation and MACE, at all levels of multimorbidity, was lower in UK Biobank than SAIL (adjusting for age, sex, and socioeconomic status). Both cohorts produced similar hazard ratios for some LTCs (e.g. hypertension and coronary heart disease) but underestimated the risk for others (e.g. alcohol problems or mental health conditions). Similarly hazard ratios for some LTC combinations were similar between the cohorts (e.g. cardiovascular, respiratory conditions), UK Biobank underestimated the risk for combinations including pain or mental health conditions. Conclusions: UK Biobank accurately estimates risk of outcomes associated with LTC counts ≤3. However, for counts ≥4 estimates of magnitude of association from UK Biobank are likely to be conservative.
引用
- Hanlon P, Bhautesh J, Mair F, et al. Multimorbidity in a selected cohort compared to a representative sample: Does selection bias influence outcomes? Ann Fam Med. 2022. PMID: 36696232. doi:10.1370/afm.20.s1.2901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。